Cargando…
A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection
Acute allograft rejection remains common after liver transplantation despite modern immunosuppressive agents. In addition, the long‐term side effects of these regimens, including opportunistic infections, are challenging. This study evaluated the safety and clinical feasibility of umbilical cord‐der...
Autores principales: | Shi, Ming, Liu, Zhenwen, Wang, Ying, Xu, Rounan, Sun, Yanling, Zhang, Min, Yu, Xi, Wang, Hongbo, Meng, Lingzhan, Su, Haibin, Jin, Lei, Wang, Fu‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702514/ https://www.ncbi.nlm.nih.gov/pubmed/29178564 http://dx.doi.org/10.1002/sctm.17-0134 |
Ejemplares similares
-
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction
por: Keller, Cesar Ariel, et al.
Publicado: (2018) -
The Immunological Basis of Liver Allograft Rejection
por: Ronca, Vincenzo, et al.
Publicado: (2020) -
The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection
por: Jia, Zhe, et al.
Publicado: (2018) -
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
por: Li, Tian-Tian, et al.
Publicado: (2022) -
The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation
por: Wang, Ying, et al.
Publicado: (2014)